REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus Oncology, Inc. (CHRS) on Monday reported a loss of $38.3 million in its first quarter.
On a per-share basis, the Redwood City, California-based company said it had a loss of 28 cents. Losses, adjusted for stock option expense and to account for discontinued operations, were 25 cents per share.
The drug developer posted revenue of $12.3 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
